|
Volumn 102, Issue 13, 2010, Pages 982-987
|
Surgical staging and treatment of early ovarian cancer: Long-term analysis from a randomized trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EARLY CANCER;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
OVARY CANCER;
OVARY TUMOR;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
DISEASE FREE SURVIVAL;
FEMALE;
KAPLAN MEIER METHOD;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
OVARIECTOMY;
PATHOLOGY;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KAPLAN-MEIERS ESTIMATE;
MIDDLE AGED;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
OVARIECTOMY;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 77954755279
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq149 Document Type: Article |
Times cited : (134)
|
References (9)
|